Английская Википедия:Alvameline
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Drugbox
Alvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist[1] that was under investigation for the treatment of Alzheimer's disease, but produced poor results in clinical trials[2] and was subsequently discontinued.
See also
References
Шаблон:Anti-dementia drugs Шаблон:Muscarinic acetylcholine receptor modulators